1 reports of this reaction
33.3% of all LOPERAMIDE HYDROCHLORIDE, SIMETHICONE reports
#1 most reported adverse reaction
CEREBROVASCULAR ACCIDENT is the #1 most commonly reported adverse reaction for LOPERAMIDE HYDROCHLORIDE, SIMETHICONE, manufactured by Safeway. There are 1 FDA adverse event reports linking LOPERAMIDE HYDROCHLORIDE, SIMETHICONE to CEREBROVASCULAR ACCIDENT. This represents approximately 33.3% of all 3 adverse event reports for this drug.
Patients taking LOPERAMIDE HYDROCHLORIDE, SIMETHICONE who experience cerebrovascular accident should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CEREBROVASCULAR ACCIDENT is a frequently reported adverse event for LOPERAMIDE HYDROCHLORIDE, SIMETHICONE, accounting for a significant proportion of all reports.
In addition to cerebrovascular accident, the following adverse reactions have been reported for LOPERAMIDE HYDROCHLORIDE, SIMETHICONE:
The following drugs have also been linked to cerebrovascular accident in FDA adverse event reports:
CEREBROVASCULAR ACCIDENT has been reported as an adverse event in 1 FDA reports for LOPERAMIDE HYDROCHLORIDE, SIMETHICONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CEREBROVASCULAR ACCIDENT accounts for approximately 33.3% of all adverse event reports for LOPERAMIDE HYDROCHLORIDE, SIMETHICONE, making it one of the most commonly reported side effect.
If you experience cerebrovascular accident while taking LOPERAMIDE HYDROCHLORIDE, SIMETHICONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.